ESC 365 - Exploring how glucagon-like peptide-1 receptor agonists reduce cardiovascular risk

ESC Premium Access

Exploring how glucagon-like peptide-1 receptor agonists reduce cardiovascular risk

Session: Experts on the spot: expanding knowledge on glucagon-like peptide-1 receptor agonists in cardiometabolic care

Topic: Diabetes and the Heart

Speaker: Doctor J. Lovshin (Toronto, CA)

Sponsored by Novo Nordisk A/S

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Julie Lovshin

Toronto (Canada)

2 presentations

0 follower

3 more presentations in this session

Glucagon-like peptide-1 receptor agonist treatment landscape: highlighting the benefits of cardiovascular risk reduction

Speaker: Doctor E. Bohula (Boston, US)

The future of cardiometabolic care: the impact of glucagon-like peptide-1 receptor agonists

Speaker: Doctor B. Scirica (Boston, US)

Connecting with the speakers: Questions and answers

Speaker: Doctor B. Scirica (Boston, US) Doctor E. Bohula (Boston, US) Doctor J. Lovshin (Toronto, CA)

Access the full session

Experts on the spot: expanding knowledge on glucagon-like peptide-1 receptor agonists in cardiometabolic care

Speakers: Doctor J. Lovshin, Doctor E. Bohula, Doctor B. Scirica, Doctor B. Scirica, Doctor E. Bohula...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources